Greg Tourangeau - 08 May 2025 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role: Principal Accounting Officer
Signature: /s/ Gregory Tourangeau
Issuer symbol: FULC
Transactions as of: 08 May 2025
Net transactions value: -$2,520
Form type: 4
Filing time: 09 May 2025, 16:15:04 UTC
Previous filing: 28 Jan 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tourangeau Greg	Principal Accounting Officer	C/O FULCRUM THERAPEUTICS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE	/s/ Gregory Tourangeau	09 May 2025	0001916566

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FULC	Common Stock	Sale	$2,520	-498	-3.4%	$5.06	14,062	08 May 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2	Includes 2,989 shares acquired under the Issuer's employee stock purchase plan on May 14, 2024.